LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the August 5, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the “Class”) of investors who purchased Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) securities between January 26, 2016 and May 19, 2016, inclusive (the “Class Period”). Neovasc investors have until August 5, 2016 to file a lead plaintiff motion.
The Complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about Neovasc's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose: (1) Neovasc's Tiara device was advanced through dishonest business practices, including the embezzlement of trade secrets from another company; (2) that there was a related and legitimate lawsuit against Neovasc regarding the misappropriation of trades secrets; and (3) consequentially, Defendants' statements about Neovasc's business, operations, and prospects were materially false and misleading at relevant times. Following this information entering the market, investors suffered damages.
If you purchased Neovasc shares, you may move the Court no later than August 5, 2016 to request appointment as lead plaintiff. To be a member of the class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to email@example.com, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.